General Information of Drug (ID: DMUVQDC)

Drug Name
JNJ-26113100
Synonyms Dermatitis agent (oral), Alza
Indication
Disease Entry ICD 11 Status REF
Atopic dermatitis EA80 Phase 2 [1]
Cross-matching ID
TTD ID
D0K9KN

References

1 ClinicalTrials.gov (NCT00455429) An Efficacy and Safety Study of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis. U.S. National Institutes of Health.